Article
Use of Human Lung Tissue Models for Screening of Drugs Against SARS-CoV-2 Infection
2022-09-20
Abstract excerpt
The repurposing of licenced drugs for use against COVID-19 is one of the most rapid ways to develop new and alternative therapeutic options to manage the ongoing pandemic. Given the approximately 8,000 licenced compounds available from Compounds Australia that can be screened, this paper demonstrates the utility of commercially-available ex vivo/3D airway and alveolar tissue models. These models are a closer repre...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a745d47d-de8d-531e-aae3-5b34b264ed63
- DOI
- 10.20944/preprints202209.0288.v1
